RhumbLine Advisers’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.53M | Buy |
87,526
+1,807
| +2% | +$114K | ﹤0.01% | 1351 |
|
|
2025
Q1 | $4.54M | Buy |
85,719
+2,988
| +4% | +$158K | ﹤0.01% | 1406 |
|
|
2024
Q4 | $4.63M | Buy |
82,731
+2,017
| +2% | +$113K | ﹤0.01% | 1458 |
|
|
2024
Q3 | $4.23M | Sell |
80,714
-2,349
| -3% | -$123K | ﹤0.01% | 1519 |
|
|
2024
Q2 | $3.41M | Buy |
83,063
+6,339
| +8% | +$260K | ﹤0.01% | 1610 |
|
|
2024
Q1 | $3.32M | Buy |
76,724
+3,552
| +5% | +$154K | ﹤0.01% | 1632 |
|
|
2023
Q4 | $3.36M | Sell |
73,172
-287
| -0.4% | -$13.2K | ﹤0.01% | 1636 |
|
|
2023
Q3 | $1.68M | Buy |
73,459
+3,861
| +6% | +$88.5K | ﹤0.01% | 1940 |
|
|
2023
Q2 | $1.15M | Buy |
+69,598
| New | +$1.15M | ﹤0.01% | 2215 |
|
|
2022
Q2 | – | Sell |
-56,942
| Closed | -$656K | – | 3218 |
|
|
2022
Q1 | $656K | Sell |
56,942
-3,595
| -6% | -$41.4K | ﹤0.01% | 2298 |
|
|
2021
Q4 | $604K | Sell |
60,537
-750
| -1% | -$7.48K | ﹤0.01% | 2432 |
|
|
2021
Q3 | $800K | Buy |
61,287
+275
| +0.5% | +$3.59K | ﹤0.01% | 2336 |
|
|
2021
Q2 | $1.2M | Buy |
61,012
+20,857
| +52% | +$409K | ﹤0.01% | 2166 |
|
|
2021
Q1 | $854K | Sell |
40,155
-1,423
| -3% | -$30.3K | ﹤0.01% | 2257 |
|
|
2020
Q4 | $1.24M | Buy |
41,578
+2,865
| +7% | +$85.2K | ﹤0.01% | 2046 |
|
|
2020
Q3 | $839K | Sell |
38,713
-5,915
| -13% | -$128K | ﹤0.01% | 2062 |
|
|
2020
Q2 | $995K | Buy |
44,628
+10,124
| +29% | +$226K | ﹤0.01% | 2048 |
|
|
2020
Q1 | $525K | Buy |
34,504
+2,109
| +7% | +$32.1K | ﹤0.01% | 2145 |
|
|
2019
Q4 | $744K | Buy |
32,395
+6,542
| +25% | +$150K | ﹤0.01% | 2209 |
|
|
2019
Q3 | $558K | Sell |
25,853
-240
| -0.9% | -$5.18K | ﹤0.01% | 2277 |
|
|
2019
Q2 | $574K | Buy |
26,093
+6,490
| +33% | +$143K | ﹤0.01% | 2306 |
|
|
2019
Q1 | $537K | Buy |
19,603
+50
| +0.3% | +$1.37K | ﹤0.01% | 2306 |
|
|
2018
Q4 | $526K | Buy |
19,553
+7,458
| +62% | +$201K | ﹤0.01% | 2278 |
|
|
2018
Q3 | $353K | Buy |
12,095
+661
| +6% | +$19.3K | ﹤0.01% | 2431 |
|
|
2018
Q2 | $357K | Buy |
+11,434
| New | +$357K | ﹤0.01% | 2454 |
|